US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.0900
  • +0.3300+18.75%
Close Nov 20 16:00 ET
  • 1.9300
  • -0.1600-7.66%
Pre 08:38 ET
5.66MMarket Cap-981P/E (TTM)

Cyclerion Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-68.47%2.87M
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-75.20%13.38M
-Cash and cash equivalents
-68.47%2.87M
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-75.20%13.38M
Receivables
--44K
----
----
--0
--0
--0
--0
-57.71%96K
-4.00%96K
-4.00%96K
-Accounts receivable
--44K
----
----
--0
--0
--0
--0
-57.71%96K
-4.00%96K
-4.00%96K
Prepaid assets
-14.46%621K
-88.89%116K
-45.68%308K
-45.09%442K
-45.09%442K
35.45%726K
61.36%1.04M
-43.69%567K
-13.25%805K
-13.25%805K
Other current assets
-63.33%11K
-97.43%11K
-98.01%10K
-97.95%11K
-97.95%11K
-93.85%30K
-11.20%428K
5.45%503K
14.74%537K
14.74%537K
Total current assets
-64.03%3.55M
-33.71%4.72M
-27.85%6.01M
-45.86%8.02M
-45.86%8.02M
-54.45%9.86M
-77.55%7.11M
-80.54%8.34M
-73.28%14.82M
-73.28%14.82M
Non current assets
Net PPE
----
----
--0
--0
--0
--0
-14.12%1.13M
-14.71%1.17M
-16.97%1.22M
-16.97%1.22M
-Gross PPE
----
----
-89.24%126K
-96.29%126K
-96.29%126K
--0
-7.89%3.29M
-67.66%1.17M
-7.31%3.4M
-7.31%3.4M
-Accumulated depreciation
----
----
---126K
94.22%-126K
94.22%-126K
----
4.28%-2.17M
----
0.86%-2.18M
0.86%-2.18M
Investments and advances
0.00%5.35M
--5.35M
--5.35M
--5.35M
--5.35M
--5.35M
----
----
--0
--0
Other non current assets
----
----
----
----
----
----
-16.41%1.86M
-15.80%1.95M
-15.21%2.04M
-15.21%2.04M
Total non current assets
0.00%5.35M
79.29%5.35M
71.42%5.35M
64.16%5.35M
64.16%5.35M
57.49%5.35M
-15.56%2.98M
-15.40%3.12M
-15.88%3.26M
-15.88%3.26M
Total assets
-41.51%8.9M
-0.32%10.07M
-0.80%11.36M
-26.02%13.37M
-26.02%13.37M
-39.27%15.21M
-71.33%10.1M
-75.38%11.46M
-69.53%18.08M
-69.53%18.08M
Liabilities
Current liabilities
Payables
-62.65%304K
-65.08%651K
-81.12%741K
-59.66%1.2M
-59.66%1.2M
-50.52%814K
-32.63%1.86M
55.82%3.93M
62.47%2.97M
62.47%2.97M
-accounts payable
-62.65%304K
-65.08%651K
-81.12%741K
-59.66%1.2M
-59.66%1.2M
-50.52%814K
-32.63%1.86M
55.82%3.93M
62.47%2.97M
62.47%2.97M
Current accrued expenses
-66.44%353K
-82.02%427K
-80.59%539K
-76.58%786K
-76.58%786K
-80.44%1.05M
-57.79%2.38M
-51.31%2.78M
-52.17%3.36M
-52.17%3.36M
Other current liabilities
-72.78%43K
16.57%204K
15.00%161K
50.00%102K
50.00%102K
-0.63%158K
-10.26%175K
-63.73%140K
-87.07%68K
-87.07%68K
Current liabilities
-70.10%700K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-31.20%7.63M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-70.10%700K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-31.20%7.63M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
----
--0
--0
Retained earnings
-2.02%-268.02M
1.11%-267.3M
0.06%-265.96M
-2.03%-264.42M
-2.03%-264.42M
-4.28%-262.72M
-11.95%-270.29M
-16.69%-266.11M
-20.49%-259.15M
-20.49%-259.15M
Paid-in capital
0.22%276.22M
0.23%276.08M
2.16%275.9M
2.26%275.72M
2.26%275.72M
2.65%275.61M
3.23%275.46M
1.86%270.05M
2.39%269.63M
2.39%269.63M
Gains losses not affecting retained earnings
--0
--0
15.79%-16K
40.00%-12K
40.00%-12K
35.71%-18K
36.00%-16K
20.83%-19K
13.04%-20K
13.04%-20K
Total stockholders'equity
-36.32%8.2M
70.54%8.78M
152.82%9.92M
8.00%11.29M
8.00%11.29M
-22.10%12.87M
-79.69%5.15M
-89.40%3.93M
-78.34%10.45M
-78.34%10.45M
Total equity
-36.32%8.2M
70.54%8.78M
152.82%9.92M
8.00%11.29M
8.00%11.29M
-22.10%12.87M
-79.69%5.15M
-89.40%3.93M
-78.34%10.45M
-78.34%10.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -68.47%2.87M-18.67%4.59M-20.55%5.7M-43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-75.20%13.38M
-Cash and cash equivalents -68.47%2.87M-18.67%4.59M-20.55%5.7M-43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-75.20%13.38M
Receivables --44K----------0--0--0--0-57.71%96K-4.00%96K-4.00%96K
-Accounts receivable --44K----------0--0--0--0-57.71%96K-4.00%96K-4.00%96K
Prepaid assets -14.46%621K-88.89%116K-45.68%308K-45.09%442K-45.09%442K35.45%726K61.36%1.04M-43.69%567K-13.25%805K-13.25%805K
Other current assets -63.33%11K-97.43%11K-98.01%10K-97.95%11K-97.95%11K-93.85%30K-11.20%428K5.45%503K14.74%537K14.74%537K
Total current assets -64.03%3.55M-33.71%4.72M-27.85%6.01M-45.86%8.02M-45.86%8.02M-54.45%9.86M-77.55%7.11M-80.54%8.34M-73.28%14.82M-73.28%14.82M
Non current assets
Net PPE ----------0--0--0--0-14.12%1.13M-14.71%1.17M-16.97%1.22M-16.97%1.22M
-Gross PPE ---------89.24%126K-96.29%126K-96.29%126K--0-7.89%3.29M-67.66%1.17M-7.31%3.4M-7.31%3.4M
-Accumulated depreciation -----------126K94.22%-126K94.22%-126K----4.28%-2.17M----0.86%-2.18M0.86%-2.18M
Investments and advances 0.00%5.35M--5.35M--5.35M--5.35M--5.35M--5.35M----------0--0
Other non current assets -------------------------16.41%1.86M-15.80%1.95M-15.21%2.04M-15.21%2.04M
Total non current assets 0.00%5.35M79.29%5.35M71.42%5.35M64.16%5.35M64.16%5.35M57.49%5.35M-15.56%2.98M-15.40%3.12M-15.88%3.26M-15.88%3.26M
Total assets -41.51%8.9M-0.32%10.07M-0.80%11.36M-26.02%13.37M-26.02%13.37M-39.27%15.21M-71.33%10.1M-75.38%11.46M-69.53%18.08M-69.53%18.08M
Liabilities
Current liabilities
Payables -62.65%304K-65.08%651K-81.12%741K-59.66%1.2M-59.66%1.2M-50.52%814K-32.63%1.86M55.82%3.93M62.47%2.97M62.47%2.97M
-accounts payable -62.65%304K-65.08%651K-81.12%741K-59.66%1.2M-59.66%1.2M-50.52%814K-32.63%1.86M55.82%3.93M62.47%2.97M62.47%2.97M
Current accrued expenses -66.44%353K-82.02%427K-80.59%539K-76.58%786K-76.58%786K-80.44%1.05M-57.79%2.38M-51.31%2.78M-52.17%3.36M-52.17%3.36M
Other current liabilities -72.78%43K16.57%204K15.00%161K50.00%102K50.00%102K-0.63%158K-10.26%175K-63.73%140K-87.07%68K-87.07%68K
Current liabilities -70.10%700K-74.09%1.28M-80.87%1.44M-72.65%2.09M-72.65%2.09M-72.55%2.34M-49.79%4.95M-20.65%7.53M-31.20%7.63M-31.20%7.63M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -70.10%700K-74.09%1.28M-80.87%1.44M-72.65%2.09M-72.65%2.09M-72.55%2.34M-49.79%4.95M-20.65%7.53M-31.20%7.63M-31.20%7.63M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0------0--0
Retained earnings -2.02%-268.02M1.11%-267.3M0.06%-265.96M-2.03%-264.42M-2.03%-264.42M-4.28%-262.72M-11.95%-270.29M-16.69%-266.11M-20.49%-259.15M-20.49%-259.15M
Paid-in capital 0.22%276.22M0.23%276.08M2.16%275.9M2.26%275.72M2.26%275.72M2.65%275.61M3.23%275.46M1.86%270.05M2.39%269.63M2.39%269.63M
Gains losses not affecting retained earnings --0--015.79%-16K40.00%-12K40.00%-12K35.71%-18K36.00%-16K20.83%-19K13.04%-20K13.04%-20K
Total stockholders'equity -36.32%8.2M70.54%8.78M152.82%9.92M8.00%11.29M8.00%11.29M-22.10%12.87M-79.69%5.15M-89.40%3.93M-78.34%10.45M-78.34%10.45M
Total equity -36.32%8.2M70.54%8.78M152.82%9.92M8.00%11.29M8.00%11.29M-22.10%12.87M-79.69%5.15M-89.40%3.93M-78.34%10.45M-78.34%10.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data